
A novel series of thiazolidine-2,4-dione (TZD) derivatives (6a–6f) was designed and synthesized through a simple and efficient synthetic route, and their structures were confirmed using FT-IR,1H NMR, 1³C NMR, and mass spectrometry. The synthesized compounds were evaluated for antimicrobial activity against Gram-positive, Gram-negative, and fungal strains, as well as for antioxidant activity using the DPPH free radical scavenging assay. The findings revealed a clear structure–activity relationship, with electron-withdrawing substituents enhancing antimicrobial activity, whereas electron-donating groups, particularly hydroxyl substitution, improved antioxidant activity. Molecular docking studies were further conducted against PBP2a (PDB ID: 2CDU) and PBP1a (PDB ID: 3UDI) to investigate the binding affinities and molecular interactions of the synthesized derivatives with relevant antimicrobial protein targets. Several compounds demonstrated favorable predicted binding affinities and molecular interactions, in some cases exceeding those of the reference drugs, supporting their potential as antimicrobial candidates. In addition, in silico ADMET analysis using SwissADME indicated favorable pharmacokinetic characteristics, good gastrointestinal absorption, and acceptable drug-likeness for most derivatives. Overall, this study identifies TZD derivatives as promising multifunctional bioactive molecules with antimicrobial and antioxidant potential, supported by molecular docking and ADMET profiling. The work also supports SDG 3 (Good Health and Well-being) by contributing to the development of new bioactive agents against microbial infections and oxidative stress-related disorders.